Management of Non-Muscle Invasive Bladder Cancer

This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.

Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.

Cover

Front Matter

  Part I. Background and Pathology on Bladder Cancer

  1. Background on Bladder Cancer

  2. Introduction to Bladder Cancer Type and Therapy

  Part II. Histological Variants in Bladder Cancer

  3. Histological Variants in Bladder Cancer—Sqaumous Cell Carcinoma and Squamous Differentiation

  4. Histological Variants in Bladder Cancer—Adenocarcinoma

  5. Histological Variants in Bladder Cancer—Sarcomatoid Differentiation

  6. Histological Variants in Bladder Cancer—Carcinosarcoma

  7. Histological Variants in Bladder Cancer—Small Cell Carcinoma

  8. Histological Variants—Plasmacytoid Bladder Cancer

  Part III. Epidemiology and Risk Factors in Bladder Cancer

  9. Introduction to Epidemiology of Bladder Cancer

  10. Epidemiology, Risk Factors and Occupational Hazards—A Systematic Review

  11. Systematic Review Results on Bladder Cancer Epidemiology, Occupational Hazards and Risk Factors

  Part IV. Assessment and Diagnostics in NMIBC

  12. Bladder Cancer—Diagnostic Pathways

  13. Systematic Review Method—Bladder Cancer Screening

  14. Bladder Cancer Screening—Systematic Review Results

  15. Bladder Cancer Screening Systematic Review Conclusion

  16. Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening

  17. Usefulness of Screening in Bladder Cancer

  Part V. Techniques in Endoscopic Resection

  18. Management of Non-Muscle Invasive Bladder Cancer

  19. A New Technique—En Bloc Resection of Bladder Tumours

  20. Prognostic Factors for Endoscopic Resection in NMIBC

  21. NMIBC and Oncological Outcomes from Endoscopic Resection

  22. Recurrence in NMIBC

  23. Definitive Treatment in NMIBC

  24. A Systematic Review of En-Bloc Resection

  25. Systematic Review—Results from En-Bloc Resection of Bladder Cancer

  Part VI. Management of Low and Intermediate Risk Bladder Cancer

  26. NMIBC—Fulguration in Low Risk Disease

  27. Active Surveillance in Non-Muscle Invasive Bladder Cancer

  28. Hyperthermic MMC—A Systematic Review

  29. Literature Related to Hyperthermic MMC

  Part VII. Management of High Risk Non-Muscle Invasive Bladder Cancer

  30. BCG—Patterns of Administration

  31. NMIBC—BCG Strain and Outcomes

  32. Adverse Effects in BCG Therapy

  33. BCG and Elderly Patients

  34. A Systematic Review of NMIBC and Intravesical Chemotherapy

  35. A Systematic Review of NMIBC and Intravesical Chemotherapy—Results

  36. What the Literature Says Re BCG

  37. Prognostic Factors in BCG

  38. Intermediate and High Risk NMIBC and BCG

  39. NMIBC, Low Dose BCG and High-Risk Disease

  40. Alternatives to BCG Therapy—MMC

  41. BCG Versus Mitomycin C—A Systematic Review

  42. What the Literature Says NMIBC—BCG or MMC

  43. NMIBC and Intravesical Chemotherapy—HIVEC I and HIVEC II

  44. BCG Refractory Disease—Oncological Outcomes

  45. NMIBC—High Grade BCG Refractory Disease

  46. A Systematic Review on Alternatives in BCG Refractory Disease

  47. Systematic Review Results on BCG Refractory Disease Management

  48. What the Literature Says on BCG Refractory Disease and Alternatives

  49. NMIBC—BCG Refractory Disease and Use of Interferon

  50. Novel Agents in BCG Refractory Disease

  51. A Scoring System for Intravesical Therapy and NMIBC

  52. High Risk NMIBC and TURBT

  53. G3T1 Bladder Cancer: Cystectomy Versus BCG

  54. A Systematic Review of High-Grade Bladder Cancer—Methods

  55. Systematic Review of G3T1 Bladder Cancer

  56. Radical Cystectomy in High Grade NMI Bladder Cancer

  Part VIII. Bladder Cancer in the Elderly and Females

  57. Bladder Cancer in the Elderly

  58. Systematic Review on Bladder Cancer Management in Elderly Patients

  59. Systematic Review—Results on Bladder Cancer Management in the Elderly

  60. Reviews Relating to Management of Bladder Cancer in the Elderly

  61. Female Outcomes in Bladder Cancer

  62. A Systematic Review on Bladder Cancer and Female Gender

  63. Systematic Review Results on Bladder Cancer and Female Gender

  64. Reviews on Female Gender and Bladder Cancer

  Part IX. Bladder Cancer Survivorship

  65. Definition of Bladder Cancer Survivorship

  66. The Impact of Bladder Cancer Survivorship

  67. Unmet Needs in Bladder Cancer Survivorship

  68. Systematic Review—Bladder Cancer Survivorship—Unmet Needs

  69. Systematic Review Search Results—Bladder Cancer Survivorship and Unmet Need

  70. Survivorship Challenges in Non-Muscle Invasive Bladder Cancer

  71. Bladder Cancer Survivorship Care Plans

  72. Research Summary—A New Model of Care for Patients with Bladder Cancer (MODA)

  73. What Is the Impact of Sexual and Emotional Concerns on Patients Post Surgery for Patients with Bladder Cancer?

  74. Results—Telephone Interviews with Thematic Analyses

  75. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 1 Erectile Dysfunction

  76. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 2 Age Related Disease

  77. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 3 Side Effects Post Operatively

  78. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact

  79. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 5 Impact of Operation on General Health

  80. Bladder Cancer Survivorship Tool

  81. Health Related Quality of Life Measurements in Bladder Cancer Survivorship

 Back Matter